Kannur university researchers get United States patent
New wish for cancer treatment
New hope for cancer treatment
A research team of the department of biotechnology and microbiology at Kannur University, making up Prof. A. Sabu, M. Haridas, and Prasanth Shankar, has been awarded a United States patent for the discovery of ‘Phormidin’ an inhibitor of the enzyme Fatty Acid Synthase (FAS).
This is the first global patent made by the university. The award offers the promise of developing a brand-new drug for cancer treatment.
The patent comes as a conclusion of almost 10 years of research study that started in 2010 with assistance from the Ministry of Earth Sciences.
According to Prof. Sabu, FAS inhibitors are anticipated to be future drugs in cancer treatment. FAS is vital for fat metabolic process, and its inhibition leads to the death of the cell.
Phormidin has great potential in the treatment of weight problems, diabetes, and tuberculosis. The brand-new hope for cancer treatment is that the drugs developed based on FAS inhibitor might have much better homes with few negative effects, Prof. Sabu pointed out.
CLICK HERE TO FIND OUT MORE
( the headline, this story has actually not been released by Important India News staff and is published from a syndicated feed.).